While, generally, DS is associated with lower-than-normal homocysteine levels, within the DS population, individuals with higher CBS expression/activity — based on the Kamoun hypothesis — would be expected to manifest with the more severe neurocognitive impairment, and the same individuals would also be expected to have the lowest plasma homocysteine levels. This evidence concerns the gene CBS and Dravet syndrome.